"The
Report Pulmonary Embolism Global Clinical Trials Review, H1, 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Pulmonary
Embolism Global
Clinical Trials Review, H1, 2016" provides an overview of
Pulmonary Embolism clinical trials scenario. This report provides top
line data relating to the clinical trials on Pulmonary Embolism.
Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report
offers coverage of disease clinical trials by region, country (G7 &
E7), phase, trial status, end points status and sponsor type. Report
also provides prominent drugs for in-progress trials (based on number
of ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at: http://www.marketresearchreports.biz/sample/sample/724102
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Table Of Content
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 13
Top
Five Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Pulmonary Embolism to
Cardiovascular Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 16
Clinical
Trials in G7 Countries by Trial Status 17
Clinical
Trials by E7 Countries: Proportion of Pulmonary Embolism to
Cardiovascular Clinical Trials 18
Clinical
Trials by Phase in E7 Countries 19
Clinical
Trials in E7 Countries by Trial Status 20
Clinical
Trials by Phase 21
In
Progress Trials by Phase 22
Clinical
Trials by Trial Status 23
Clinical
Trials by End Point Status 24
Subjects
Recruited Over a Period of Time 25
Clinical
Trials by Sponsor Type 26
Prominent
Sponsors 27
Top
Companies Participating in Pulmonary Embolism Therapeutics Clinical
Trials 28
Prominent
Drugs 30
Latest
Clinical Trials News on Pulmonary Embolism 31
Mar
23, 2016: Boehringer Ingelheim launches RE-COVERY DVT/PE: global
observational study on management of Deep Vein Thrombosis and
Pulmonary Embolism with Pradaxa (dabigatran etexilate) 31
Clinical
Trial Profile Snapshots 32
Appendix
156
Abbreviations
156
Definitions
156
Research
Methodology 157
Secondary
Research 157
About
GlobalData 158
Contact
Us 158
Disclaimer
158
Source
159
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment